baber/WOPTO huggingface dataset:
Patent NZ-298178-A (NZ)
Title: Catheter manufacture: injection moulded apertured tip, standard tube formed tip connection and hydrophilic material coating
Inventor: UTAS JAN
IPC: B29C65/02
Filed: 1995-12-20
Abstract: PCT No. PCT/SE95/01558 Sec. 371 Date Jan. 30, 1996 Sec. 102(e) Date Jan. 30, 1996 PCT Filed Dec. 20, 1995 PCT Pub. No. WO96/19254 PCT Pub. Date Jun. 27, 1996A process for manufacturing a catheter for insertion into a body cavity, for instance a catheter used for insertion into the urethra. The catheter has a tip portion provided with one or several drainage or flushing openings adjacent to the free end which is to be inserted into the body cavity. The outside of the catheter is provided with a coating. The process includes injection-molding a separate tip portion of the catheter. The tip portion includes an inner lumen and the drainage/flushing openings. The inner and outer diameters of the tip correspond to those of a standard tube. An end of a standard tube and an end of the tip portion are formed to conform to each other. These formed ends are then joined in a joining operation. The coating is applied to the standard tube before the joining operation is performed.
Patent NZ-333402-A (NZ)
Title: Derivatized rhodamine dye and its copolymers
Inventor: WARD WILLIAM J
IPC: C09B11/28
Filed: 1997-07-11
Abstract: Disclosed are the Rhodamine B esters of hydroxy C2-C6 lower alkyl acrylates. Specifically, the hydroxy lower alkyl radical is a linear hydroxy lower alkyl radical having the hydroxy group attached to the terminal carbon atom . Also shown are copolymers of diallyldimetyl ammonium chloride which contains from 0.01-2 mole percent of these Rhodamine B esters and their use in treating industrial waters.
Patent NZ-500504-A (NZ)
Title: Garage door panel construction with hinged connected moulded polymer panels, with specific hinge details
Inventor: MORGAN BRIAN H
IPC: E06B3/48
Filed: 1998-05-14
Abstract: A series of rectangular horizontal, garage door panels (10, 12) are joined together by integral hinge elements (40) which enables the panels (10, 12) to be manufactured at a factory site and assembled at a construction site. The panels (10, 12) as well as the hinge elements (40) may be fabricated from a fiberglass, reinforced, composite or other polymeric materials to enhance the durability of the garage door construction.
Patent NZ-503497-A (NZ)
Title: Accessing billing data via different stations in a network
Inventor: GANESAN RAVI
Filed: 2000-03-21
Abstract: To access data over a network having a plurality of stations, information that identifies the data, such as a bill, that is available at a second billing station is stored at a first central customer server network station.  In response to a request for information identifying the available bill from a third customer station, the request is authenticated and the central server station generates a signal representing the information identifying the available bill and linking information to the billing station which is transmitted to the customer station.  At the customer station the linking information is operative to establish a network link over which the identified available bill is transmittable from the billing station to the customer station.  When the bill is transmitted from the billing station to the customer station, the central server station is notified and the request receipt and notification are logged.
Patent NZ-503498-A (NZ)
Title: Central tracking of transactions in networked electronic billing system
Inventor: GANESAN RAVI
IPC: G06Q20/00
Filed: 2000-03-21
Abstract: To centrally track transactions in an electronic billing system including multiple different billing entities, financial institute entities, and user entities, with each of the billing entities and financial institute entities being associated with some of the user entities, a message from a financial institute entity indicative of a request from a user entity to view billing information is received and this request is logged in a database as first event information.  In response to the request, a message indicative of the billing information of at least one of the associated billing entities is transmitted to the applicable user entity for viewing.  A message indicative of a request from the applicable user entity to view the available billing information of a billing entity is received from the applicable billing entity and this request is also logged in the database as second event information, which may be correlated to the first event information.
Patent NZ-504471-A (NZ)
Title: An Ox receptor distinct from known alpha 2-adenoreceptors and imidazoline receptors (I1 and I2) with an affinity for compounds of the oxazoline class
Inventor: GUNDLACH ANDREW L
IPC: C07D279/06
Filed: 1998-11-05
Abstract: Disclosed is a receptor, in particular a type of receptor with an affinity for compounds of the oxazoline class.  Also described are compounds that bind to this receptor, and the use of these compounds in the treatment of diseases, especially diseases of the central nervous system, the cardiovascular system and the kidney.
Patent NZ-506367-A (NZ)
Title: Treating mammalian skin lesions with a composition comprising 8-hydroxyquinoline, a metal chelating agent and a carrier
Inventor: JORDAN RUSSEL T
IPC: A61K33/24
Filed: 1999-02-10
Abstract: Oxinates including 8-hydroxyquinoline and a heavy metal are  topically applied to epidermal lesions for  therapeutic effect. A   composition  for  use  in  treating  epithelial  lesions comprising  :  8-hydroxyquinoline; a metal chelating  agent; and  a carrier, wherein the 8-hydroxyquinoline and the metal chelating  agent  are  present in therapeutically  effective amounts  for  treating mammalian lesions selected  from  the group   consisting   of   cancerous  lesions,   precancerous lesions, cysts, and warts. This    therapeutic   composition   demonstrates   selective toxicity with a therapeutic index of one hundred percent  on human  lung cancer, breast cancer, melanoma, venereal warts, male  veruoca  warts, lesions produced  by  human  papilloma virus,  basal  cell carcinoma, solarkeratosis, and  Kaposi's sarcoma.  In veterinary applications where dogs,  cats,  and horses  are  the  patients,  the  composition  shows  a  one hundred  percent  therapeutic index with selective  toxicity against  eye cancer, sarcoids, sarcoma, malignant  melanoma, rectal adenoma, histiocytoma, and sebaceous adenoma.
Patent NZ-506907-A (NZ)
Title: Welder having selection between generator power and utility power by switching
Inventor: FOSBINDER DANIEL
IPC: B23K9/10
Filed: 2000-09-12
Abstract: Welder 100 has input circuit having either engine power input or utility electrical power input. Switch 108 is used to select either option.
Patent NZ-509467-A (NZ)
Title: Method for hair repair, styling and straightening
Inventor: YAMASHITA YUKO
IPC: A61Q5/02
Filed: 2000-01-11
Abstract: A method for hair repair and straightening comprising: 1) rinsing out a neutralizer solution from hair; 2) applying a conditioner to said hair; 3) blow-drying said hair; and 4) re-compressing said hair under heat.
Patent NZ-510496-A (NZ)
Title: A method where groups of associated nodes are able to transmit all or parts of incoming packets from mobile nodes to other nodes
Inventor: MEIER PETER SIEGFRIED
IPC: H04L12/56
Filed: 2001-03-13
Abstract: The appearance of rapid movement of a mobile node between a plurality of base nodes (by individual movement or local effects) can cause several handoffs to occur between bases in a single packet transmission. This causes delays or loss in data, which are very apparent in voice transmissions. To overcome this, a system is employed where a group of base nodes are given information regarding the state of the current transmitted packet.  This method begins with the servicing of a mobile node within a group of stationary nodes. One of more of the stationary nodes then receives the packet to be sent to the mobile node. Then, a part of the packet is transmitted to the mobile and an acknowledgement of reception of that packet is awaited. Once received, the acknowledgement is transmitted to the whole group of stationary nodes.
Patent NZ-511773-A (NZ)
Title: Compositions and methods for treating hair and skin using aqueous delivery systems
Inventor: CANNELL DAVID W
IPC: A61K8/00
Filed: 1999-12-08
Abstract: Compositions containing at least one organic phospholipid capable of forming bilayers in aqueous solution; and at least one amphoteric surfactant and at least one nonionic surfactant, each present in an amount by weight equal to or greater than the amount of the phospholipid; where the phospholipid and surfactants are present in a combined amount sufficient to allow at least one water- insoluble ingredient selected from waxes and unneutralized and partially neutralized water-insoluble polymers, resins, and latexes to be incorporated into an aqueous solution. A delivery system containing the composition and methods for styling hair and for treating keratinous substances are also disclosed.
Patent NZ-521897-A (NZ)
Title: Surgical drape of polymeric film with low glare finish and predetermined coloration
IPC: A61B19/08
Filed: 2002-10-10
Abstract: A surgical drape is provided of predetermined coloration for low glare. Such a drape is stated to substantially eliminate eye strain.
Patent NZ-531362-A (NZ)
Title: Regulation of cytotrophoblast cell differentiation and cell migration
Inventor: ROBERTS CLAIRE
IPC: A61K38/30
Filed: 2002-08-30
Abstract: A method of in vitro regulating proteolytic conversion of latent TGF-beta1 to active TGF-beta1 by CIM6P receptor expressed on a cell, the method including modulating binding of IGF-II to the CIM6P receptor expressed on the cell and thereby regulate the conversion of latent TGF-beta1 to active TGF-beta1.
Patent NZ-531408-A (NZ)
Title: Topical formulation comprising a lipophilic anthracycline for the treatment of neoplastic or preneoplastic processes of a body surface
Inventor: BYMOSE BJARNE
IPC: A61K47/10
Filed: 2002-08-12
Abstract: Described are pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the treatment of psoriasis is described, preferably to treatment of psoriasis with valrubicin topically applied.
Patent NZ-531522-A (NZ)
Title: Herbicidal composition comprising S-metolachlor and foramsulfuron
Inventor: CORNES DEREK
IPC: A01N43/70
Filed: 2002-09-19
Abstract: A herbicidal composition comprises a mixture of S-metolachlor and a synergistically effective amount of foramsulfuron. The composition can be used for controlling undesirable plant growth in crops of useful plants.
Patent NZ-534525-A (NZ)
Title: Teether with U-shaped mouth engaging portion for orthodontically optimised engagement
Inventor: SANBROOK PETER NEWTON
IPC: A61J17/00
Filed: 2003-02-05
Abstract: A teether comprising a mouth-engageable portion, a handle, and a shield, wherein the mouth-engageable portion is generally U-shaped so as to define upper and lower surfaces and outer ends, and dimensioned to be engageable between the upper and lower teeth of a user, which mouth-engageable portion is relatively thicker at and adjacent the outer ends and relatively thinner in a centre region generally midway between the outer ends adjacent to the shield.
Patent NZ-534601-A (NZ)
Title: Zip end stop and zip incorporating such
Inventor: STEWART MATTHEW JAMES
Filed: 2004-08-09
Abstract: A plastics zip for clothing has two mutually engagable male (203) and female (204) zip profiles of generally uniform cross section along the whole or part of their length and merged or de-merged within a special slider (115). The slider has two guide slots (not shown) which join to create a Y-shaped passageway within the body of the slider and side slits (not shown) to allow the slider to move along the fixed tapes or flanges of the zip profiles. One of the guide slots contains an expansion element (not shown) which opens the jaws of the female profile allowing it pass over and capture the smaller male profile so that the zip is merged. Movement of the slider in the opposite direction allows the two profiles to be de-merged and exit from the slider.
Patent NZ-535126-A (NZ)
Title: System for managing program stored in storage unit of mobile terminal
Inventor: KAWABATA HIROSHI
IPC: G06F9/445
Filed: 2002-05-14
Abstract: A program management system for management of an application that is executable on a mobile terminal comprises: a server configured to manage an application that is destined for a mobile terminal wherein the server is configured to store a secret key of the server and a public key receivable by the server; and the server is configured to first decrypt a received application with the public key and then decrypt the received application with the secret key. A program management system for management of an application that is executable on a mobile terminal comprises: a server having a control unit that is configured to control receipt of an application that is destined for a mobile terminal wherein the control unit is also configured to control operation of a cryptographic key storing unit and an application information storing unit included in the server; wherein the cryptograph key storing unit is configured to store a secret key of the server and a public key of the mobile terminal that is receivable by the server; and wherein the control unit is configured to first direct encryption of a received application with the public key of the mobile terminal and then direct encryption of the application with the secret key prior to transmission of the application for receipt by the mobile terminal. (62) Divided out of 523068
Patent NZ-537535-A (NZ)
Title: The use of oligonucleotide or polynucleotide primers for use in the detection of Mycobacterium avium subspecies paratuberculosis
Inventor: MURRAY ALAN
IPC: A61K39/00
Filed: 2003-06-19
Abstract: One or more oligonucleotides or polynucleotide probes or primers for use in the detection of Mycobacterium avium subspecies paratuberculosis consisting of SEQ ID NO:2. The probes or primers does not encode the polypeptide comprising the amino acid sequence of SEQ ID NO:1. Also disclosed is a diagnostic composition for detecting the presence of Mycobacterium avium subspecies paratuberculosis and a method of detecting Johne's disease comprising contacting a sample from the animal with a composition comprising a probe or primer disclosed above.
Patent NZ-538375-A (NZ)
Title: Prefabricated concrete wall panel with top tongue and lower groove for interengagement of panels
Filed: 2005-02-21
Abstract: The wall panel has a top tongue and a lower groove for inter-engagement of panels. Optionally the sides may be sloped relative to each other for corner connections.
Patent NZ-538936-A (NZ)
Title: Combination drug comprising a combination of a dipeptidyl peptidase IV (DPPIV) inhibitor with biguanide
Inventor: YASUDA NOBUYUKI
IPC: A61P43/00
Filed: 2003-09-22
Abstract: A pharmaceutical agent comprising a dipeptidyl peptidase IV inhibitor and a biguanide agent in combination is disclosed, wherein the dipeptidyl peptidase IV inhibitor is a compound represented by the following formula (I), or a salt or hydrate thereof. These pharmaceutical agents are suitable for potentiating the effect of activated glucagon-like peptide-1 (GLP-1) in blood and/or activated glucagon-like peptide-2 (GLP-2) in blood and are useful as a preventive or therapeutic agent for a disease which is associated with active circulating GLP-1 and/or active circulating GLP-2.
Patent NZ-539211-A (NZ)
Title: Neurologically-active compounds
Inventor: KOK GAIK BENG
IPC: A61K31/436
Filed: 2003-10-03
Abstract: Disclosed are neurologically-active compounds, being heterocyclic compounds having two fused 6-membered with at least one ring being aromatic of formula I. Also disclosed are processes for the preparation of these compounds and their use as pharmaceutical or veterinary agents, in particular for the treatment of neurological conditions, more specifically neurodegenerative conditions such as Alzheimer's disease.
Patent NZ-540717-A (NZ)
Title: Biphenyl derivatives and their use as fungicides
Inventor: EHRENFREUND JOSEF
IPC: A01N43/80
Filed: 2003-12-15
Abstract: Disclosed is a compound of formula (I) where Het is a pyrazole, pyrrole or thiazole ring, the ring substituted by one, two or three groups Ry; R1 is hydrogen; R2, R3 and R4 are each independently, hydrogen, halogen, methyl or CF3; R5 is hydrogen or fluorine; Each R6 is independently, halogen, methyl or CF3; R7 is (Z)mCC(Y1); Each Ry is independently halogen, C1-3 alkyl, C1-3 haloalkyl, C1-3 alkoxy(C1-3)alkylene or cyano; X is O; and the remainder of the substituents are described in the specification. Also disclosed is a method of controlling or preventing infestation of cultivated plants by phytopathogenic microorganisms by application of a compound of formula (I) to parts thereof or the locus thereof.
Patent NZ-541934-A (NZ)
Title: Carbonated milk product comprising a combination of agents that control the foaming of the product while retaining an effective effervescence in the carbonated milk-based beverage
Inventor: REVELL RICHARD ALAN
Filed: 2005-08-19
Abstract: A composition for addition to a milk or milk-based beverage, the composition including the following components, on a w/w basis (to a total of 100%): 1. Silica between about 1% to about 10%; 2. Vegetable oil between about 20% to about 90%; and 3. Polyglycol mix between about 10% to about 90%. The composition allowing control of foaming and frothing in the beverage as a result of carbonation.
Patent NZ-546577-A (NZ)
Title: Linear fluorescent high-bay
Inventor: HAUGAARD ERIC J
IPC: F21V29/00
Filed: 2004-10-04
Abstract: A method for implementing lighting utilizes a lighting fixture having a plurality of lateral reflector positions, including selectively installing a first type reflector panel or a second type reflector panel in individual ones of the plurality of lateral reflector positions, the first type reflector panel having a greater uplighting capacity compared to the second type reflector panel, whereby the selectively installing determines, for the lighting fixture, a proportion of uplight versus downlight. For a plurality of tube positions disposed in a plane, a method may include vertically positioning a reflector assembly with respect to the plane. Individual reflector panels may be replaced by flexing the panel. A method may include providing a sensor switch operative to detect an occupant and connect an electrical path when the occupant is detected, and providing a selector for selecting ones of the ballasts to be connected to the electrical path by the sensor switch.
Patent NZ-546945-A (NZ)
Title: A plant host cell system for the expression of human GnTIII
Inventor: BAKKER HENDRIKUS ANTONIUS CORN
IPC: A61K38/00
Filed: 2003-03-18
Abstract: Disclosed is a plant host cells system comprising a mammalian GnTIII enzyme and a hetrologous glycoprotein, wherein said hetrologous glycoprotein or functional fragment thereof comprises bisected oligosaccharides. Further to this, GnTIII is human GnTIII. (62) Divided Out of 534881
Patent NZ-551338-A (NZ)
Title: Method of improving the production of foam during the preparation of drinks from a cartridge and device for its implementation
Inventor: DENISART JEAN-LUC
IPC: A23P30/40
Filed: 2005-06-09
Abstract: A method is disclosed of obtaining a frothy drink from a cartridge, the said cartridge being made up of at least one chamber containing at least a preparation for a drink. The method comprises injecting into the said cartridge a predetermined volume of fluid, a first part of which essentially consists of air which is compressed in the cartridge to a pressure lower than the pressure at which the cartridge opens or the drink flows freely through the said cartridge and a second part of which consists of water, or possibly of a mixture of air and water, which is injected after the first part into the cartridge so as to make it possible to obtain the drink by causing the internal pressure to increase until the cartridge opens or the drink flows freely through the cartridge thus allowing the drink to be discharged and froth to be formed.
Patent NZ-551566-A (NZ)
Title: Providing freezing and thawing resistance to cementitious compositions
Inventor: CHRISTENSEN BRUCE J
IPC: C04B16/08
Filed: 2005-06-14
Abstract: The disclosure relates to a cementitious freeze-thaw damage resistant wet cast composition adapted to be exposed to freeze-thaw cycles comprising hydraulic cement, gas generating additives, and flexible polymeric microspheres, wherein the flexible polymeric microspheres have an average diameter of about 100 micrometers or less.
Patent NZ-551859-A (NZ)
Title: Pyrimidine derivatives as 11beta-HSD1 inhibitors
Inventor: AMREIN KURT
IPC: A61K31/506
Filed: 2005-06-20
Abstract: Pyrimidine derivative compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof are disclosed, wherein R1 to R5 are as defined in the specification. These compounds can be used in the form of pharmaceutical compositions for the treatment and prophylaxis of diabetes, obesity, eating disorders, dyslipidemiae and hypertension.
Patent NZ-563957-A (NZ)
Title: A label having a temperature-monitoring function, a package for goods provided with a label, as well as a method and equipment for the application of labels to packages for goods
Inventor: NORRBY HENRY
IPC: B41M5/40
Filed: 2006-03-29
Abstract: Disclosed is a label comprising, on one hand, a colouring substance of the type that has the capacity of producing a print by the effect of heat, the colour of which print contrasts with the base colour of the label, and on the other hand an agent having the purpose of, at least partially, destroying the contrast between said colours, if the label is exposed to a temperature above a predetermined maximum value, the label having a surface field for a print (3) containing coded information, characterized in that the same is manufactured from a porous, capillary-suctioning substrate (5), and that said agent is included in a loading of a substance (7), which is solid at temperatures up to said maximum value, but becomes liquid above the same, and which loading of is located beside the surface field of the print (3). Also disclosed is a package for the storage of goods in a temperature range having a predetermined maximum value, comprising the above label, and an apparatus for the application of the above labels to packages is further disclosed.
Patent NZ-567371-A (NZ)
Title: Flow generator message system for air flow CPAP apparatus to provides messages at predetermined intervals
Inventor: OATES JOHN DAVID
IPC: A61M16/00
Filed: 2006-10-13
Abstract: Disclosed is a flow generator configured to provide a supply of pressurized breathable gas to a patient, as in a CPAP apparatus. The flow generator comprises a processor coupled with operation sensors, a clock and a user interface. The processor is programmed to generate at least one time-based message at predetermined time intervals based on either time of use or elapsed time. The user interface delivers the message to at least one of a display, a flow generator service provider, the patient and a physician.